Radiofrequency Ablation For Chronic Migraine ââ?¬â?? A Randomized Controlled Trial
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/05/042401
- Lead Sponsor
- Department of Neurosurgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with chronic or drug refractory migraine
2.Patients who had >50% relief with local anesthetic block (0.5% Bupivacaine).
Exclusion Criteria
Patient refusal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the pain outcomes of RF ablation for migraine using Visual analog score and migraine headache indexTimepoint: 7 days, 1 month, 3 months, 6 months, 12 months
- Secondary Outcome Measures
Name Time Method To study the functional outcomes of RF ablation for migraine using Migraine disability assessment test (MIDAS score) and Pain self-efficacy questionnaire (PSEQ)Timepoint: 7 days, 1 month, 3 months, 6 months, 12 months